Concourse Financial Group Securities, Inc. Gilead Sciences, Inc. Transaction History
Concourse Financial Group Securities, Inc.
- $1.67 Billion
- Q4 2024
A detailed history of Concourse Financial Group Securities, Inc. transactions in Gilead Sciences, Inc. stock. As of the latest transaction made, Concourse Financial Group Securities, Inc. holds 4,340 shares of GILD stock, worth $446,195. This represents 0.02% of its overall portfolio holdings.
Number of Shares
4,340
Previous 2,810
54.45%
Holding current value
$446,195
Previous $235,000
70.21%
% of portfolio
0.02%
Previous 0.01%
Shares
26 transactions
Others Institutions Holding GILD
# of Institutions
2,172Shares Held
991MCall Options Held
8.71MPut Options Held
9.4M-
Black Rock Inc. New York, NY121MShares$12.4 Billion0.19% of portfolio
-
Vanguard Group Inc Valley Forge, PA116MShares$11.9 Billion0.19% of portfolio
-
Capital World Investors Los Angeles, CA71.7MShares$7.37 Billion1.05% of portfolio
-
State Street Corp Boston, MA60.4MShares$6.21 Billion0.23% of portfolio
-
Capital Research Global Investors Los Angeles, CA57.9MShares$5.96 Billion1.15% of portfolio
About GILEAD SCIENCES, INC.
- Ticker GILD
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 1,253,369,984
- Market Cap $129B
- Description
- Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...